Sign in to fuzzto save your conversations, follow your research and come back anytime.
Sunrest Lifescience
SectorHealthcare
| Metric (₹ crore) | Q4 FY23 | Q1 FY24 | Q2 FY24 |
|---|---|---|---|
| Sales | 6.84 | 5.64 | 6.84 |
| Expenses | 7.16 | 4.63 | 6.19 |
| EBITDA | -0.32 | 1.01 | 0.65 |
| Depreciation | 0.03 | 0.02 | 0.02 |
| EBIT | -0.35 | 0.99 | 0.63 |
| Interest | 0.04 | 0.01 | 0.01 |
| Profit Before Tax | -0.39 | 0.98 | 0.62 |
| Net Profit | -0.32 | 0.75 | 1.23 |
| EPS | 0 | 2.5 | 4.12 |
| Metric (₹ crore) | FY25 | FY26 |
|---|---|---|
| Operating Cash Flow | 2.92 | -0.05 |
| Investing Cash Flow | -1.15 | -2.91 |
| Financing Cash Flow | -0.33 | 3.99 |
| Net Cash Flow | 1.44 | 1.03 |
| Metric (₹ crore) | FY25 | FY26 |
|---|---|---|
| Equity / Shareholders' Funds | 21.63 | 29.63 |
| Total Liabilities | 37.02 | 41.79 |
| Total Assets | 58.65 | 71.41 |